Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus
- PMID: 6283119
- PMCID: PMC256749
- DOI: 10.1128/JVI.41.1.271-285.1982
Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus
Abstract
A cloned, permuted DNA copy of the Abelson murine leukemia virus (A-MuLV) genome was capable of eliciting the morphological transformation of NIH/3T3 fibroblasts when applied to cells in a calcium phosphate precipitate. The efficiency of the process was extremely low, yielding approximately one transformant per microgram of DNA under conditions which give 10(4) transfectants per microgram of other DNAs (e.g., Moloney sarcoma virus proviral DNA). The DNA was able to induce foci, even though the 3' end of the genome was not present. The transforming gene was thus localized to the 5' portion of the genome. The transformed cells all produced viral RNA and the virus-specific P90 protein. Transmissible virus could be rescued from these cells at very low frequencies by superinfection with helper virus; the rescued A-MuLV virus had variable 3' ends apparently derived by recombination with the helper. Dimerization of the permuted A-MuLV cloned genome to reconstruct a complete provirus did not improve transformation efficiency. Virus could be rescued from these transformants, however, at a high efficiency. Cotransfection of the permuted A-MuLV DNA with proviral M-MuLV DNA yielded a significant increase in the efficiency of transformation and cotransfection of dimeric A-MuLV and proviral M-MuLV resulted in a high-efficiency transformation yielding several thousand more transformants per microgram than A-MuLV DNA alone. We propose that helper virus efficiently rescues A-MuLV from transiently transfected cells which would not otherwise have grown into foci. We hypothesize that multiple copies of A-MuLV DNA introduced into cells by transfection are toxic to cells. In support of this hypothesis, we have shown that A-MuLV DNA sequences can inhibit the stable transformation of cells by other selectable DNAs.
Similar articles
-
Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.J Virol. 1987 Oct;61(10):3266-75. doi: 10.1128/JVI.61.10.3266-3275.1987. J Virol. 1987. PMID: 3041046 Free PMC article.
-
Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA.Proc Natl Acad Sci U S A. 1981 Apr;78(4):2077-81. doi: 10.1073/pnas.78.4.2077. Proc Natl Acad Sci U S A. 1981. PMID: 6264461 Free PMC article.
-
Transformation of NIH3T3 cells by A-MuLV proviral DNA: effect of plasmid linearization and carrier DNA on transformation efficiency.Oncogene. 1989 Nov;4(11):1411-3. Oncogene. 1989. PMID: 2554240
-
The Abelson murine leukemia virus oncogene.Proc Soc Exp Biol Med. 1985 Sep;179(4):403-12. doi: 10.3181/00379727-179-42115. Proc Soc Exp Biol Med. 1985. PMID: 2991935 Review. No abstract available.
-
Transcriptional regulation of mammalian genes in vivo. A tale of two templates.J Biol Chem. 1997 Oct 31;272(44):27493-6. doi: 10.1074/jbc.272.44.27493. J Biol Chem. 1997. PMID: 9346875 Review. No abstract available.
Cited by
-
N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.EMBO J. 1989 Feb;8(2):449-56. doi: 10.1002/j.1460-2075.1989.tb03397.x. EMBO J. 1989. PMID: 2542016 Free PMC article.
-
Characterization of unintegrated retroviral DNA with long terminal repeat-associated cell-derived inserts.J Virol. 1992 Oct;66(10):5735-43. doi: 10.1128/JVI.66.10.5735-5743.1992. J Virol. 1992. PMID: 1382140 Free PMC article.
-
Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.EMBO J. 1992 Nov;11(11):3941-51. doi: 10.1002/j.1460-2075.1992.tb05488.x. EMBO J. 1992. PMID: 1396587 Free PMC article.
-
Evidence for preferential copackaging of Moloney murine leukemia virus genomic RNAs transcribed in the same chromosomal site.Retrovirology. 2005 Jan 18;2:3. doi: 10.1186/1742-4690-2-3. Retrovirology. 2005. PMID: 15656910 Free PMC article.
-
The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation.Mol Cell Biol. 1995 Mar;15(3):1286-93. doi: 10.1128/MCB.15.3.1286. Mol Cell Biol. 1995. PMID: 7862122 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources